Metraipolis › archive › dc_374be818acdd
Beyond inflammation: metabolic implications of biological and TsDMARD therapies in dermatologic and rheumatologic diseases — Europe PMC PMID:41766878
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41766878
- DOI
- 10.3389/fimmu.2026.1668159
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T21:31:08.003Z
- SHA-256 of the archived text
fa62d65f6ff1cbff518f73fc964b5f7bf3bbf9399c30a070797b3e1d58393eb9- Stable URL of this page
https://metraipolis.com/documento/dc_374be818acdd
How to cite
Beyond inflammation: metabolic implications of biological and TsDMARD therapies in dermatologic and rheumatologic diseases — Europe PMC PMID:41766878 — Europe PMC (en), https://europepmc.org/article/MED/41766878 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_374be818acdd (Metraipolis archive dc_374be818acdd, sha256 fa62d65f6ff1cbff518f73fc964b5f7bf3bbf9399c30a070797b3e1d58393eb9)
BibTeX
@misc{dc374be818acdd,
title = {Beyond inflammation: metabolic implications of biological and TsDMARD therapies in dermatologic and rheumatologic diseases — Europe PMC PMID:41766878},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41766878},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_374be818acdd; sha256 fa62d65f6ff1cbff518f73fc964b5f7bf3bbf9399c30a070797b3e1d58393eb9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41766878. Agents can read the archived copy with the MCP tool read_document.